NoPrescriptionDrugstore.com Order Status FAQ Online Drugstore Affiliate Program Contact NoPrescriptionDrugstore.com No Prescription Drugs Newsletter Refer a Friend
 
Monday, October 27, 2008  
National Vaccine Information Center Says Government Denies Gardasil Risks (No Prescription)
National Vaccine Information Center Says Government Denies Gardasil Risks
The National Vaccine Information Center (NVIC) is calling on the Centers for Disease Control (CDC) and Food and Drug Administration (FDA) to publicly release the study design, data and names of principal investigators involved in a statement this week maintaining that Gardasil vaccine is safe with no serious side effects.
Source: www.medicalnewstoday.com

Environmental Nanoparticles: Science, Ethics & Policy: Workshop At UD, Nov. 10-11
The University of Delaware will host "Environmental Nanoparticles: Science, Ethics & Policy" on Nov. 10-11 at the John M. Clayton Hall Conference Center in Newark, Del.
Source: www.medicalnewstoday.com

Veterinary Medicines Information Leaflet Available From The National Pharmacy Association, UK
The NPA has updated its information leaflet on Veterinary Medicines in response to the Veterinary Regulations 2008. The resource is available to download from the NPA's members' website. The information leaflet is designed to summarise the important issues surrounding the supply of veterinary medicines. The resource outlines the classification of veterinary medicines, prescription and supply restrictions and requirements.
Source: www.medicalnewstoday.com

Sie Foundation Launches Campaign To Expand Research By Government And Private Sector For Down Syndrome
The Anna and John J. Sie Foundation today launched a major campaign to change the nation's approach to Down syndrome. The Foundation's goal is to significantly increase public and private research aimed at eradicating the ill effects associated with the chromosomal disorder and improve the health outcomes for the 400,000 people in the United States, and millions worldwide, with the condition.
Source: www.medicalnewstoday.com

ARIAD Presents Preclinical Data On Kinase Inhibitor, AP24534, Demonstrating Mechanism-Based Activity In Solid Tumors
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today presented, for the first time, results of studies on its investigational, multi-targeted kinase inhibitor - AP24534 - showing anti-tumor activity in preclinical cancer models. These data were released at the EORTC-NCI-AACR (ENA) symposium on "Molecular Targets and Cancer Therapeutics" held in Geneva, Switzerland this week.
Source: www.medicalnewstoday.com

Veterinary Medicines Information Leaflet Available From The National Pharmacy Association, UK
The NPA has updated its information leaflet on Veterinary Medicines in response to the Veterinary Regulations 2008. The resource is available to download from the NPA's members' website. The information leaflet is designed to summarise the important issues surrounding the supply of veterinary medicines.
Source: www.medicalnewstoday.com

ILADS President Calls For More Comprehensive Dialogue To Prevent Chronic Lyme Disease
During his closing remarks at the 2008 Scientific Meeting hosted by the International Lyme and Associated Diseases Society (ILADS), Dr. Daniel Cameron, ILADS president, stressed the need for more comprehensive dialogue between physicians and researchers regarding the prevention of chronic Lyme disease.
Source: www.medicalnewstoday.com

MRSA Is More Prevalent In Paediatric Healthcare Than Previously Thought - Birmingham Children's Hospital, UK
Birmingham Children's Hospital has introduced a new way of detecting the MRSA superbug amongst its most critically ill young patients. The test, developed by molecular diagnostics company Cepheid, has so far proven to be 100% accurate and is allowing doctors at the hospital to identify if a patient to be admitted to the ICU has MRSA within an hour.
Source: www.medicalnewstoday.com

Subscribe to Posts [Atom]

Home | Order Status | FAQ | Affiliates | Contact us | Newsletter | Refer a Friend

© 2004 Online Pharmacy. All Rights Reserved.